New Content  edit

An Interactive CME-Certified Symposium

Keeping It Real: Reversing Effects of Anticoagulation in the Modern Era with Real World Data

An Interactive CME-Certified Symposium

Tuesday, 27 June 2023
13:15 – 14:30
Montreal, Quebec, Canada

Attend In Person:
Palais des congress de Montreal
Room 710A
1001 Place Jean-Paul-Riopelle
Montreal, Quebec, Canada
Dessert provided

Watch Online:
Live Streamed on MedEd On The Go

This event has concluded. Thank you to all who presented and attended. This symposium will soon be available on-demand at MedEd On The Go.

This satellite symposium will be conducted during the International Society on Thrombosis and Haemostasis (ISTH) 2023 Congress in Montreal, Quebec, Canada. This activity is not associated with the ISTH 2023 Congress.

Symposium Overview

The introduction and assessment of real-world data (RWD) associated with FXa inhibitor-related bleeds is of critical importance in treatment-emergent situations, as there has been limited information disseminated to date within the relatively complex clinical landscape. This program focuses on the role of reversal agents in the presence of life-threatening bleeds while on an anticoagulant. It covers the most recent key RWD published relative to the use of reversal or repletion strategies in anticoagulated patients.


Jan Beyer-Westendorf, MD, PhD

University Hospital Carl Gustav Carus Dresden
Dresden, Germany


Craig I. Coleman, PharmD, FASHP, FACC

University of Connecticut
Hartford Hospital
Connecticut, USA

Deborah Siegal, MD, MSc, FRCPC

The Ottawa Hospital
University of Ottawa
Ottawa, Canada

Deepa J. Arachchillage, MRCP, FRCPath, MD

Imperial College London
London Imperial College Healthcare NHS Trust
London, United Kingdom

Full Accreditation and Program Information


Registration & Dessert
Welcome & Introductions
RWE Overview and Considerations
Major Bleeding Considerations
Reversal Considerations for the Future
Audience Q&A
Symposium Ends

Target Audience

This activity has been designed to meet the educational needs of the interprofessional team, including hematology, vascular medicine, vascular surgery, pulmonology/critical care, neurology, gastroenterology, trauma, hospital medicine, emergency medicine, cardiology, and internal medicine, as well as other clinicians involved in the management of patients on anticoagulation with life-threatening bleeding.

Learning Objectives

After completing this activity, the participant should be better able to:

  • Evaluate recent practice-changing data that can be applied to practice in the presence of a life-threatening bleed in the presence of anticoagulation
  • Apply latest evidence-based approaches to maximize management prognostic outcomes for life-threatening bleeds in the presence of anticoagulation

Accreditation Information

Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Global Learning Collaborative (GLC) and TotalCME, Inc. GLC is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credits for learning and change.

Fee Information : There is no fee for this educational activity.

A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be emailed to you.

Participants will be invited to complete an evaluation form at the end of the event. A statement of credit will be issued upon receipt of the evaluation form. If you are a registered user of MedEd On The Go, you will receive a certificate in your online bank immediately upon completion. If you complete a paper form, a certificate will be manually processed and emailed to you.

Supported by an independent educational grant from AstraZeneca.
Jointly provided by the Global Learning Collaborative (GLC) and TotalCME, Inc.